APA (7th ed.) Citation

Deepak Chellapandian & Diana Milojevic. (2023). Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Deepak Chellapandian and Diana Milojevic. Case Report: Emapalumab for Active Disease Control Prior to Hematopoietic Stem Cell Transplantation in Refractory Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Deepak Chellapandian and Diana Milojevic. Case Report: Emapalumab for Active Disease Control Prior to Hematopoietic Stem Cell Transplantation in Refractory Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome. Frontiers Media S.A., 2023.